CPSE:HLUN BPharmaceuticals
H. Lundbeck (CPSE:HLUN B) After Strong Q2 Results Is The Stock A Bargain Or Priced Right
Why H. Lundbeck stock is in focus after Q2 2026
H. Lundbeck (CPSE:HLUN B) is back on investor radars after reporting second quarter 2026 earnings, with higher sales and net income, and confirming full year guidance supported by demand for its key pharmaceutical brands.
Following the earnings release and confirmed 2026 guidance, H. Lundbeck’s share price, now at DKK42.2, has seen a modest 1-day share price return of 1.88%, while the 90-day share price return is down 4.57%. However, the 3-year...